OBJECTIVE: Executive dysfunction may play a key role in the pathophysiology of late-life depression. Executive dysfunction can be assessed with cognitive tests and subjective report of difficulties with executive skills. The present study investigated the association between subjective report of executive functioning complaints and time to escitalopram treatment response in older adults with major depressive disorder (MDD). METHODS: 100 older adults with MDD (58 with executive functioning complaints and 42 without executive functioning complaints) completed a 12-week trial of escitalopram. Treatment response over 12 weeks, as measured by repeated Hamilton Depression Rating Scale scores, was compared for adults with and without executive complaints using mixed-effects modeling. RESULTS: Mixed effects analysis revealed a significant group × time interaction, F(1, 523.34) = 6.00, p = 0.01. Depressed older adults who reported executive functioning complaints at baseline demonstrated a slower response to escitalopram treatment than those without executive functioning complaints. CONCLUSION: Self-report of executive functioning difficulties may be a useful prognostic indicator for subsequent speed of response to antidepressant medication.
OBJECTIVE: Executive dysfunction may play a key role in the pathophysiology of late-life depression. Executive dysfunction can be assessed with cognitive tests and subjective report of difficulties with executive skills. The present study investigated the association between subjective report of executive functioning complaints and time to escitalopram treatment response in older adults with major depressive disorder (MDD). METHODS: 100 older adults with MDD (58 with executive functioning complaints and 42 without executive functioning complaints) completed a 12-week trial of escitalopram. Treatment response over 12 weeks, as measured by repeated Hamilton Depression Rating Scale scores, was compared for adults with and without executive complaints using mixed-effects modeling. RESULTS: Mixed effects analysis revealed a significant group × time interaction, F(1, 523.34) = 6.00, p = 0.01. Depressed older adults who reported executive functioning complaints at baseline demonstrated a slower response to escitalopram treatment than those without executive functioning complaints. CONCLUSION: Self-report of executive functioning difficulties may be a useful prognostic indicator for subsequent speed of response to antidepressant medication.
Authors: George S Alexopoulos; Dimitris N Kiosses; Sibel Klimstra; Balkrishna Kalayam; Martha L Bruce Journal: Am J Geriatr Psychiatry Date: 2002 Jan-Feb Impact factor: 4.105
Authors: Virginia Elderkin-Thompson; Anand Kumar; Warren B Bilker; Jennifer J Dunkin; Jim Mintz; Paul J Moberg; Raquelle I Mesholam; Ruben E Gur Journal: Arch Clin Neuropsychol Date: 2003-07 Impact factor: 2.813
Authors: Guy G Potter; Joshua D Kittinger; H Ryan Wagner; David C Steffens; K Ranga Rama Krishnan Journal: Neuropsychopharmacology Date: 2004-12 Impact factor: 7.853
Authors: Joel R Sneed; Steven P Roose; John G Keilp; K Ranga Rama Krishnan; George S Alexopoulos; Harold A Sackeim Journal: Am J Geriatr Psychiatry Date: 2007-07 Impact factor: 4.105
Authors: Sarah Shizuko Morimoto; Dora Kanellopoulos; Kevin J Manning; George S Alexopoulos Journal: Ann N Y Acad Sci Date: 2015-02-05 Impact factor: 5.691
Authors: Davangere P Devanand; Gregory H Pelton; Kristina D'Antonio; Adam Ciarleglio; Jennifer Scodes; Howard Andrews; Julia Lunsford; John L Beyer; Jeffrey R Petrella; Joel Sneed; Michaela Ciovacco; Pudugramam Murali Doraiswamy Journal: Am J Geriatr Psychiatry Date: 2018-06-28 Impact factor: 4.105
Authors: Jeffrey N Motter; Gregory H Pelton; Kristina D'Antonio; Sara N Rushia; Monique A Pimontel; Jeffrey R Petrella; Ernst Garcon; Michaela W Ciovacco; Joel R Sneed; P Murali Doraiswamy; Davangere P Devanand Journal: Int J Geriatr Psychiatry Date: 2018-07-23 Impact factor: 3.485
Authors: Shefali Miller; Lisa M McTeague; Anett Gyurak; Brian Patenaude; Leanne M Williams; Stuart M Grieve; Mayuresh S Korgaonkar; Amit Etkin Journal: Depress Anxiety Date: 2015-04-27 Impact factor: 6.505
Authors: Shawn M McClintock; Jimmy Choi; Zhi-De Deng; Lawrence G Appelbaum; Andrew D Krystal; Sarah H Lisanby Journal: J ECT Date: 2014-06 Impact factor: 3.635
Authors: Matteo Respino; Matthew J Hoptman; Lindsay W Victoria; George S Alexopoulos; Nili Solomonov; Aliza T Stein; Maria Coluccio; Sarah Shizuko Morimoto; Chloe J Blau; Lila Abreu; Katherine E Burdick; Conor Liston; Faith M Gunning Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2019-11-07